Patient-Tailored Combinations of Systemic and Topical Preparations for Localized Peripheral Neuropathic Pain: A Two-Case Report

REFERENCES

• Zur E. Topical treatment of neuropathic pain using compounded medications. Clin J Pain. Jan 2014;30(1):73–91.
   PubMed Web of Science ®Google Scholar
• Almeida H, Amaral MH, Lobao P, Lobo JM. Pluronic(R) F-127 and pluronic lecithin organogel (PLO): Main features and their applications in topical and transdermal administration of drugs. J Pharm Pharm Sci. 2012;15(4):592–605.
   PubMed Web of Science ®Google Scholar
• Devor M. Ectopic discharge in Abeta afferents as a source of neuropathic pain. Exp Brain Res. 2009;196(1):115–28.
   PubMed Web of Science ®Google Scholar
• Latremoliere A, Woolf CJ. Central sensitization: A generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.
   Google Scholar
• Weinbroum AA, Rudick V, Paret G, Ben-Abraham R. The role of dextromethorphan in pain control. Can J Anaesth. 2000;47(6):585–96.
   Google Scholar
• Shaibani AI, Pope LE, Thisted R, Hepner A. Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: A double-blind, placebo-controlled, multicenter study. Pain Med. 2012;13(2):243–54.
   Google Scholar
• Ben Abraham R, Marouani N, Kollender Y, Meller I, Weinbroum AA. Dextromethorphan for phantom pain attenuation in cancer amputees: A double-blind crossover trial involving three patients. Clin J Pain. 2002;18(5):282282-85.
   Google Scholar
• Ben Abraham R, Marouani N, Weinbroum AA. Dextromethorphan mitigates phantom pain in cancer amputees. Ann Surg Oncol. 2003;10(3):268282-74.
   Google Scholar
• Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology. 1997;48(5):1212–18.
   Google Scholar
• Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: Efficacy and dose-response trials. Anesthesiology. 2002;96(5):1053–61.
   Google Scholar
• Carlsson KC, Hoem NO, Moberg ER, Mathisen LC. Analgesic effect of dextromethorphan in neuropathic pain. Acta Anaesthesiol Scand. 2004;48(3):328–36.
   Google Scholar
• Blonk MI, Koder BG, van den Bemt PM, Huygen FJ. Use of oral ketamine in chronic pain management: A review. Eur J Pain. 2010;14(5):466–72.
   Google Scholar
• Soto E, Stewart DR, Mannes AJ, Ruppert SL, Baker K, Zlott D, Handel D, Berger AM. Oral ketamine in the palliative care setting: A review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome. Am J Hosp Palliat Care. 2012;29(4):308–17.
   Google Scholar
• Sawynok J. Topical analgesics for neuropathic pain: Preclinical exploration, clinical validation, future development. Eur J Pain. 2014;18(4):465–81.
   Google Scholar
• Chong C, Schug SA, Page-Sharp M, Jenkins B, Ilett KF. Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study. Clin Drug Investig. 2009;29(5):317-24.
   PubMedGoogle Scholar
• Kannan TR, Saxena A, Bhatnagar S, Barry A. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J Pain Symptom Manage. 2002;23(1):60–65.
   Google Scholar
• Weinbroum AA. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg. 2003;96(3):789–95, table of contents.
   Google Scholar
• Mercadante S, Arcuri E, Ferrera P, Villari P, Mangione S. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage. 2005;30(5):485–91.
   Google Scholar
• Kadic L, Niesten E, Heijnen I, Hofmans F, Wilder-Smith O, Driessen JJ, Malefijt MC. The effect of addition of pregabalin and s-ketamine to local infiltration analgesia on the knee function outcome after total knee arthroplasty. Acta Anaesthesiol Belg. 2012;63(3):111-14.
   Google Scholar
• Martinez V, Cymerman A, Ben Ammar S, Fiaud JF, Rapon C, Poindessous F, Judet T, Chauvin M, Bouhassira D, Sessler D, Mazoit X, Fletcher D. The analgesic efficiency of combined pregabalin and ketamine for total hip arthroplasty: A randomised, double-blind, controlled study. Anaesthesia. 2014;69(1):46–52.
   Google Scholar
• Happich M, Schneider E, Boess FG, Wilhelm S, Schacht A, Birklein F, Ziegler D. Effectiveness of duloxetine compared to pregabalin and gabapentin in diabetic peripheral neuropathic pain: Results from a German observational study. Clin J Pain. 2014;30(10):875–885
   PubMedGoogle Scholar
• Pergolizzi JV, Jr., Raffa RB, Taylor R, Jr., Rodriguez G, Nalamachu S, Langley P. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract. 2013;13(3):239–52.
   Google Scholar
• Wang Y, Huang H, Zeng Y, Wu J, Wang R, Ren B, Xu F. Pharmacist-led medication education in cancer pain control: A multicentre randomized controlled study in Guangzhou, China. J Int Med Res. 2013;41(5):1462–72.
   Google Scholar
• Chen J, Lu XY, Wang WJ, Shen B, Ye Y, Jiang H, Wang QS, Cheng B. Impact of a clinical pharmacist-led guidance team on cancer pain therapy in China: A prospective multicenter cohort study. J Pain Symptom Manage. 2014;48(4):500–509
   PubMedGoogle Scholar
• CCIOMS WORKING GROUP IV. Benefit-risk balance of marketed drugs: Evaluating drug signals. 1998. Available at: http://www.cioms.ch/publications/g4-benefit-risk.pdf Accessed January 1, 2014.
   Google Scholar
• United Nations Department of Economic and Social Affairs. Consolidated List of Products Whose Consumption and/or Sale have been Banned, Withdrawn, Severely Restricted or not Approved by Governments (12th ed.). Available at: http://www.un.org/esa/coordination/CL12.pdf. Accessed January 1, 2014.
   Google Scholar
• Allen LV. Ketamine hydrochloride 10-mg troches. US Pharmacist. 2009;34:58-59.
   Google Scholar
• Rogalski MJ, Kellogg-Spadt S, Hoffmann AR, Fariello JY, Whitmore KE. Retrospective chart review of vaginal diazepam suppository use in high-tone pelvic floor dysfunction. Int Urogynecol. 2010;21(7):895-99.
   Google Scholar